Skip to main content
Erschienen in: International Journal of Clinical Oncology 6/2016

15.06.2016 | Original Article

Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy

verfasst von: Takeshi Shin, Tomohiro Kobayashi, Yukihito Shimomura, Toshiyuki Iwahata, Keisuke Suzuki, Takashi Tanaka, Mai Fukushima, Megumi Kurihara, Akane Miyata, Yoshitomo Kobori, Hiroshi Okada

Erschienen in: International Journal of Clinical Oncology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Combinations of surgery, radiation therapy, and chemotherapy can achieve high remission rates in patients with cancer, but these treatments can have damaging effects on spermatogenesis. In particular, cytotoxic chemotherapy may lead to irreversible spermatogenic dysfunction. Microdissection testicular sperm extraction (micro-TESE) is the only method that can address infertility in cancer survivors with persistent postchemotherapy azoospermia.

Methods

We included 66 Japanese patients with postchemotherapy azoospermia who underwent micro-TESE for sperm retrieval in this analysis. Age, oncology data, hormone profiles, and outcomes of micro-TESE and subsequent intracytoplasmic sperm injections (ICSIs) were reviewed.

Results

The common disease in our patients was testicular cancer (21 patients), followed by acute lymphoblastic leukemia and Hodgkin’s lymphoma (nine patients). In this cohort of 66 patients, sperm was successfully retrieved in 31 patients (47 %), and clinical pregnancy occurred in 23 cases (35 %). The live birth rate was 27 %. No significant differences in sperm retrieval, clinical pregnancy, and live birth rates were seen between testicular cancer, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, or sarcoma cases. Multiple logistic regression analysis showed that the chance of retrieving sperm during micro-TESE could not be predicted by any variable.

Conclusions

Cryopreservation of sperm should be offered before any gonadotoxic chemotherapy takes place. However, micro-TESE and subsequent ICSI could be effective treatment options for patients with persistent postchemotherapy azoospermia whose sperm were not frozen before therapy. Our results suggest that micro-TESE-ICSI could benefit 27 % of such Japanese patients.
Literatur
1.
Zurück zum Zitat Shin T, Iwahata T, Kobori Y et al (2016) Chromosomal abnormalities in 1354 Japanese patients with azoospermia due to spermatogenic dysfunction. Int J Urol 23:188–189CrossRefPubMed Shin T, Iwahata T, Kobori Y et al (2016) Chromosomal abnormalities in 1354 Japanese patients with azoospermia due to spermatogenic dysfunction. Int J Urol 23:188–189CrossRefPubMed
2.
Zurück zum Zitat Dabaja AA, Schlegel PN (2013) Microdissection testicular sperm extraction: an update. Asian J Androl 15:35–39CrossRefPubMed Dabaja AA, Schlegel PN (2013) Microdissection testicular sperm extraction: an update. Asian J Androl 15:35–39CrossRefPubMed
3.
Zurück zum Zitat Shin T, Miyata A, Arai G et al (2015) Fertility in testicular cancer patients (in Japanese). Gan To Kagaku Ryoho (Cancer Chemother) 42:267–271 Shin T, Miyata A, Arai G et al (2015) Fertility in testicular cancer patients (in Japanese). Gan To Kagaku Ryoho (Cancer Chemother) 42:267–271
4.
Zurück zum Zitat Loren AW, Mangu PB, Beck LN et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500–2510CrossRefPubMed Loren AW, Mangu PB, Beck LN et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500–2510CrossRefPubMed
5.
Zurück zum Zitat Okada H, Dobashi M, Yamazaki T et al (2002) Conventional versus microdissection testicular sperm extraction for nonobstructive azoospermia. J Urol 168:1063–1067CrossRefPubMed Okada H, Dobashi M, Yamazaki T et al (2002) Conventional versus microdissection testicular sperm extraction for nonobstructive azoospermia. J Urol 168:1063–1067CrossRefPubMed
6.
Zurück zum Zitat Walters EM, Benson JD, Woods EJ et al (2009) The history of sperm cryopreservation. In: Pacey AA, Tomlinson M (eds) Sperm banking theory and practice. Cambridge University Press, London, pp 1–17CrossRef Walters EM, Benson JD, Woods EJ et al (2009) The history of sperm cryopreservation. In: Pacey AA, Tomlinson M (eds) Sperm banking theory and practice. Cambridge University Press, London, pp 1–17CrossRef
7.
Zurück zum Zitat Meistrich ML, Finch M, da Cunha MF et al (1982) Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res 42:122–131PubMed Meistrich ML, Finch M, da Cunha MF et al (1982) Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res 42:122–131PubMed
8.
Zurück zum Zitat Sigman M (2013) Cancer treatment and male infertility: effects of therapy and current and future management options. Fertil Steril 100:1179–1186CrossRefPubMed Sigman M (2013) Cancer treatment and male infertility: effects of therapy and current and future management options. Fertil Steril 100:1179–1186CrossRefPubMed
9.
Zurück zum Zitat Meistrich ML, Wilson G, Mathur K et al (1997) Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin’s disease. J Clin Oncol 15:3488–3495PubMed Meistrich ML, Wilson G, Mathur K et al (1997) Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin’s disease. J Clin Oncol 15:3488–3495PubMed
10.
Zurück zum Zitat Meistrich ML (2009) Effect of antineoplastic and other medical treatments on sperm production. In: Pacey AA, Tomlinson M (eds) Sperm banking theory and practice. Cambridge University Press, London, pp 18–29CrossRef Meistrich ML (2009) Effect of antineoplastic and other medical treatments on sperm production. In: Pacey AA, Tomlinson M (eds) Sperm banking theory and practice. Cambridge University Press, London, pp 18–29CrossRef
11.
Zurück zum Zitat Gordon W, Siegmund K, Stanisic TH et al (1997) A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Int J Radiat Oncol Biol Phys 38:83–94CrossRefPubMed Gordon W, Siegmund K, Stanisic TH et al (1997) A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Int J Radiat Oncol Biol Phys 38:83–94CrossRefPubMed
12.
Zurück zum Zitat Naysmith TE, Blake DA, Harvey VJ et al (1998) Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod 13:3250–3255CrossRefPubMed Naysmith TE, Blake DA, Harvey VJ et al (1998) Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod 13:3250–3255CrossRefPubMed
13.
Zurück zum Zitat Meseguer M, Garrido N, Remohí J et al (2003) Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy. Hum Reprod 18:1281–1285CrossRefPubMed Meseguer M, Garrido N, Remohí J et al (2003) Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy. Hum Reprod 18:1281–1285CrossRefPubMed
14.
Zurück zum Zitat Tomlinson M (2010) Therapeutic sperm cryopreservation. In: Björndahl L, Giwercman A, Tournaye L (eds) Clinical andrology EAU/ESAU course guidelines. Informa Health Care, London, pp 124–133CrossRef Tomlinson M (2010) Therapeutic sperm cryopreservation. In: Björndahl L, Giwercman A, Tournaye L (eds) Clinical andrology EAU/ESAU course guidelines. Informa Health Care, London, pp 124–133CrossRef
15.
Zurück zum Zitat Schlegel PN (1999) Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Hum Reprod 14:131–135CrossRefPubMed Schlegel PN (1999) Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Hum Reprod 14:131–135CrossRefPubMed
16.
Zurück zum Zitat Palermo G, Joris H, Devroey P et al (1992) Pregnancies after intracytoplasmic injection of single spermatozoa into an oocyte. Lancet 340:17–18CrossRefPubMed Palermo G, Joris H, Devroey P et al (1992) Pregnancies after intracytoplasmic injection of single spermatozoa into an oocyte. Lancet 340:17–18CrossRefPubMed
17.
Zurück zum Zitat Hsiao W, Stahl PJ, Osterberg EC et al (2011) Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol 29:1607–1611CrossRefPubMed Hsiao W, Stahl PJ, Osterberg EC et al (2011) Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol 29:1607–1611CrossRefPubMed
18.
Zurück zum Zitat Shiraishi K, Matsuyama H (2014) Microdissection testicular sperm extraction and salvage hormonal treatment in patients with postchemotherapy azoospermia. Urology 83:100–106CrossRefPubMed Shiraishi K, Matsuyama H (2014) Microdissection testicular sperm extraction and salvage hormonal treatment in patients with postchemotherapy azoospermia. Urology 83:100–106CrossRefPubMed
19.
Zurück zum Zitat Williams DH IV, Karpman E, Sander JC et al (2009) Pretreatment semen parameters in men with cancer. J Urol 181:736–740CrossRefPubMed Williams DH IV, Karpman E, Sander JC et al (2009) Pretreatment semen parameters in men with cancer. J Urol 181:736–740CrossRefPubMed
20.
Zurück zum Zitat Suzuki K, Shin T, Shimomura Y et al (2015) Spermatogenesis in tumor-bearing testes in germ cell testicular cancer patients. Hum Reprod 30:2853–2858PubMed Suzuki K, Shin T, Shimomura Y et al (2015) Spermatogenesis in tumor-bearing testes in germ cell testicular cancer patients. Hum Reprod 30:2853–2858PubMed
Metadaten
Titel
Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy
verfasst von
Takeshi Shin
Tomohiro Kobayashi
Yukihito Shimomura
Toshiyuki Iwahata
Keisuke Suzuki
Takashi Tanaka
Mai Fukushima
Megumi Kurihara
Akane Miyata
Yoshitomo Kobori
Hiroshi Okada
Publikationsdatum
15.06.2016
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 6/2016
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-016-0998-5

Weitere Artikel der Ausgabe 6/2016

International Journal of Clinical Oncology 6/2016 Zur Ausgabe

Letter to the Editor

Prevalence of data fraud

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.